Literature DB >> 30878081

Dirofilaria immitis and D. repens in dog and cat: A questionnaire study in Italy.

Marco Genchi1, Laura Rinaldi2, Luigi Venco3, Giuseppe Cringoli2, Alice Vismarra4, Laura Kramer4.   

Abstract

Dirofilaria immitis and D. repens are vector-borne parasites of dogs and cats, with zoonotic potential, endemic in many parts of Europe, including Italy. Control and prevention of dirofilariosis are essential points to reduce their diffusion in animals and humans and veterinarians are the main subjects involved in this "battle". With the aim to better understand current practice by veterinarians, an online questionnaire on different aspects of D. immitis and D. repens was sent to companion animal veterinary facilities registered with the Italian Veterinary chamber. The overall response rate was 25%. Approximately 47% had diagnosed at least one case of Dirofilaria spp. in dogs in the last year and approximately 6% had diagnosed at least one case of Dirofilaria spp. in cats. Of the 662 facilities surveyed, 83.8% used serology to diagnose heartworm infection. For the diagnosis of D. repens infection in dogs and cats, a high percentage of facilities relied on an external laboratory. Most recommended beginning prevention of canine heartworm disease in April-May. Topical and injectable moxidectin and oral ivermectin were the two most commonly used preventives for D. immitis in dogs. The drug most commonly used for heartworm adulticide treatment in dogs was melarsomine. This study show that veterinary facilities ians working in an endemic area for D. immitis and D. repens are aware of recent developments in adulticide therapy. Results would suggest however that diagnosis is not always carried out according to what is currently recommended by international guidelines and that the timing for starting prevention may not be optimal.
Copyright © 2019. Published by Elsevier B.V.

Entities:  

Keywords:  Cat; Diagnosis; Dirofilaria immitis; Dirofilaria repens; Dog; Epidemiology; Italy; Questionnaire; Treatment

Mesh:

Substances:

Year:  2019        PMID: 30878081     DOI: 10.1016/j.vetpar.2019.01.014

Source DB:  PubMed          Journal:  Vet Parasitol        ISSN: 0304-4017            Impact factor:   2.738


  5 in total

1.  Estimated specific antibody-based true sero-prevalences of canine filariosis in dogs in Central Europe and the UK.

Authors:  Paul Torgerson; Peter Deplazes; Jeannine E Fehr; Manuela Schnyder; Deborah E Joekel; Nikola Pantchev; Mindaugas Sarkunas
Journal:  Parasitol Res       Date:  2022-10-19       Impact factor: 2.383

2.  Seroprevalence of Feline Heartworm in Spain: Completing the Epidemiological Puzzle of a Neglected Disease in the Cat.

Authors:  José Alberto Montoya-Alonso; Sara Nieves García Rodríguez; Elena Carretón; Iván Rodríguez Escolar; Noelia Costa-Rodríguez; Jorge Isidoro Matos; Rodrigo Morchón
Journal:  Front Vet Sci       Date:  2022-05-12

3.  Differential ABC transporter gene expression in adult Dirofilaria immitis males and females following in vitro treatment with ivermectin, doxycycline or a combination of both.

Authors:  Chiara Lucchetti; Marco Genchi; Luigi Venco; Alessandro Menozzi; Paolo Serventi; Simone Bertini; Chiara Bazzocchi; Laura Helen Kramer; Alice Vismarra
Journal:  Parasit Vectors       Date:  2019-08-13       Impact factor: 3.876

4.  A molecular survey of vector-borne pathogens and haemoplasmas in owned cats across Italy.

Authors:  Maria Stefania Latrofa; Roberta Iatta; Federica Toniolo; Tommaso Furlanello; Silvia Ravagnan; Gioia Capelli; Bettina Schunack; Bruno Chomel; Andrea Zatelli; Jairo Mendoza-Roldan; Filipe Dantas-Torres; Domenico Otranto
Journal:  Parasit Vectors       Date:  2020-04-21       Impact factor: 3.876

5.  Leishmania infantum and Dirofilaria immitis infections in Italy, 2009-2019: changing distribution patterns.

Authors:  Jairo Mendoza-Roldan; Giovanni Benelli; Rossella Panarese; Roberta Iatta; Tommaso Furlanello; Frederic Beugnet; Andrea Zatelli; Domenico Otranto
Journal:  Parasit Vectors       Date:  2020-04-15       Impact factor: 3.876

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.